Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Go back to Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
Harvard Bioscience, Inc. (NASDAQ: HBIO) Delayed: 7.98 +0.02 (0.25%)
Previous Close $7.96    52 Week High $3.90 
Open $7.96    52 Week Low $2.25 
Day High $8.07    P/E N/A 
Day Low $7.92    EPS $-0.03 
Volume 32,314